Predictive value of PD-L1 expression in response to immune checkpoint inhibitors for esophageal cancer treatment: A systematic review and meta-analysis

BACKGROUND: Programmed death-ligand-1 (PD-L1) molecule is a well-known predictive biomarker for the efficacy of immune checkpoint inhibitors (ICIs) in several cancers. Present systematic review and meta-analysis aimed at investigating the role of PD-L1 in predicting the effectiveness of programmed d...

Descripción completa

Detalles Bibliográficos
Autores principales: Noori, Maryam, Yousefi, Amir-Mohammad, Zali, Mohammad Reza, Bashash, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798008/
https://www.ncbi.nlm.nih.gov/pubmed/36591463
http://dx.doi.org/10.3389/fonc.2022.1021859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798008/
https://www.ncbi.nlm.nih.gov/pubmed/36591463
http://dx.doi.org/10.3389/fonc.2022.1021859

Ejemplares similares